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Abstract
It has been shown that flap endonuclease-1 (FEN-1), a structure-specific nuclease, acts on the removal of RNA primers
during Okazaki fragment maturation in DNA synthesis. To study whether the gene expression of FEN-1 is inducible during
cell proliferation, we analyzed the FEN-1 mRNA levels in actively growing cells and non-growing cells. The gene expression
of FEN-1 was higher in mitotic cells than in resting cells, and was markedly decreased, especially, when terminal
differentiation was induced in promyelocytic leukemia cells (HL-60 cells). The decline correlated substantially with the
ceasing of DNA synthesis. In the examination of tissue-specific gene expression, the human testis, spleen, thymus and
mucosal lining of colon tissues expressed this gene actively, whereas the prostate, ovary, small intestine and peripheral blood
leukocyte hardly expressed it. In addition, FEN-1 was co-localized with the proliferating cell nuclear antigen (PCNA) in
young rat kidney according to immunohistochemistry. These findings suggest that FEN-1 gene expression is inducible during
cell proliferation for DNA synthesis, and is down-regulated during cell differentiation. ß 2000 Elsevier Science B.V. All
rights reserved.
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1. Introduction
Flap endonuclease-1 (FEN-1) is a structure-specif-
ic nuclease which recognizes 5P-branched £ap DNA
and removes the unannealed single-stranded region
[1]. It also exhibits 5PC3P exonuclease activity with a
speci¢city for double-stranded DNA containing 5P-
recessed ends [1]. Mammalian FEN-1 was cloned
from murine [2] and human cells [3^4]. On the basis
of its nuclease activity and deduced amino acid se-
quence, it has been understood that FEN-1 is the
same enzyme as the maturation factor I (MF I) [4],
which acts in SV40 DNA replication in vitro [5].
Because calf 5PC3P exonuclease and yeast RTH1
also have the same enzyme activity and speci¢city
for DNA substrates as murine FEN-1 [6^7], they
are regarded as calf and yeast FEN-1 homolog, re-
spectively. In addition, several archaebacterial FEN-
1s were newly cloned and their recombinant proteins
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were characterized extensively [8^9]. Therefore, it
seems that FEN-1 gene is highly conserved from pro-
karyotes to eukaryotes.
It has been demonstrated that the calf FEN-1 ho-
molog acts on the removal of RNA primer with its
exo- or endonuclease activity during Okazaki frag-
ment processing in a lagging strand DNA synthesis
[10^13]. The FEN-1 can also interact with the pro-
liferating cell nuclear antigen (PCNA) [14^16], which
is a auxiliary factor for DNA polymerases N and O.
These facts suggest that the PCNA, with its ring-like
structure, loads onto a double stranded DNA by
encircling it, and then physically interacts with
FEN-1 in order to recruit FEN-1 at the DNA repli-
cation fork.
According to a mapping study on the binding site,
PCNA binds to FEN-1 at the region at which PCNA
binds to p21Cip1 [15^16]. It has been understood that
one of the important antiproliferative roles of p21Cip1
is the inhibition of DNA replication by PCNA^
p21Cip1 binding. Presumably, the p21Cip1 blocks cell
proliferation through inhibition of PCNA’s role in
recruiting FEN-1 as well as DNA polymerases at
DNA replication sites.
Using an in vitro system, recent studies have dem-
onstrated that the FEN-1 plays an important role in
DNA replication [10^12]. To date, however, little is
known about the regulation of this gene expression
in cells. We have studied on FEN-1 gene expression,
and found that the gene expression was down-regu-
lated in di¡erentiated promyelocytic leukemia cells
[17]. The down-regulation was not speci¢c to di¡er-
entiation-lineage (granulocytic or monocytic), be-
cause all of the mRNA levels were decreased in cases
of granulocytic di¡erentiation by all-trans retinoic
acid (RA) or dimethyl sulfoxide (DMSO), and
monocytic di¡erentiation by 12-O-tetradecanoyl
phorbol-13-acetate (TPA). It is likely that this gene
expression can be blocked in the non-growing cells in
which DNA replication is no longer needed. There-
fore, we further studied in order to con¢rm a rela-
tionship between FEN-1 gene expression and DNA
synthesis. In this study, FEN-1 gene expression was
analyzed during cell proliferation, in which DNA
synthesis progresses actively, and during cell di¡er-
entiation, in which it is blocked entirely. The tissue-
speci¢c human FEN-1 gene expression was also in-
vestigated.
2. Materials and methods
2.1. Cells and cell di¡erentiation
Peripheral blood granulocytes and lymphocytes
were separated from healthy volunteers’ blood by
Ficoll-Hypaque centrifugation as described in [18].
The lymphocytes were activated by 100 Wg/ml of
phytohemagglutinin P (PHA) in RPMI 1640 medium
(Sigma, St. Louis, MO) supplemented with 10% FCS
(HyClone, Logan, UT).
The HL-60 promyelocytic leukemia cell line was
obtained from the American Type Culture Collection
(Rockville, MD), and maintained in RPMI 1640 me-
dium containing 10% FCS. To induce cell di¡eren-
tiation, the HL-60 cells were plated at a density of
1^2U105/ml in a medium containing 1.3% DMSO
(Sigma), 1 WM RA (Sigma) or 100 nM TPA (Sigma),
and then cultured for 5^7 days. The cell di¡erentia-
tion was evaluated by morphological changes in
Giemsa staining [19] and the reduction of c-myc
gene expression [20].
2.2. In vivo DNA synthesis
To check DNA synthesis during di¡erentiation,
1^2U105/ml of HL-60 cells were seeded in 24-well
plates (Corning, Corning, NY), cultured with or
without di¡erentiating inducers, and incubated with
[3H]thymidine (NEN, Boston, MA) at 10 WCi/ml for
2 h before harvesting. The labeled cells were washed
with PBS twice, resuspended in 1 ml of cold 10%
TCA (Sigma), and then stood on ice for 20 min.
The precipitates were collected on Whatman GF/A
¢lters (Whatman, Maidstone, UK). After washing
the ¢lters with cold 10% TCA twice, radioactivity
was measured using a liquid scintillation counter
(Beckman LS 6500).
2.3. Preparation of anti-FEN-1 antibody
The DE3 cells (E. coli strain BL21), which were
transformed by pET-FCH plasmid containing hu-
man FEN-1 cDNA, were obtained from Dr. Min
S. Park, Los Alamos National Laboratory (Los Ala-
mos, NM). The FEN-1 protein, which was overex-
pressed in DE3 cells, was puri¢ed by a⁄nity column
chromatography under non-denaturing conditions
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using Ni2-Sepharose (Invitrogen, Carlsbad, CA).
The antibody was then produced by immunizing rab-
bits with the puri¢ed recombinant human FEN-1,
followed by isolating the IgG fraction using the Im-
munoPure IgG Puri¢cation Kit (Pierce, Rockford,
IL) according to the manufacturer’s directions.
2.4. Immunohistochemistry
Five-day-old Sprague^Dawley rats were deeply
anesthetized with 4% chloral hydrate (1 ml/100 mg)
and perfused transcardially with PBS, followed by
4% paraformaldehyde (Sigma) in 0.1 M phosphate
bu¡er (pH 7.2). Kidneys were dissected and post¢xed
in the same ¢xative for 4 h at 4‡C. After being rinsed
in PBS, tissue was dehydrated in a graded series of
ethanol and embedded in wax (polyethylene glycerol
400 disterate; Polysciences, Warrington, PA). Con-
secutive transverse sections of 3 Wm were immuno-
stained using the avidin^biotin^horseradish peroxi-
dase technique (Vectastain ABC kit; Vector,
Burlington, CA). In brief, the sections were dewaxed,
rehydrated, and incubated with 3% H2O2 for 30 min
to eliminate endogenous peroxidase activity. After
treatment with blocking serum for 1 h, the consec-
utive sections were incubated with rabbit polyclonal
antibody against FEN-1 (dilution rate 1:10) or
mouse monoclonal anti-PCNA antibody (Dako,
Denmark, dilution rate 1:100) at 4‡C overnight. Sec-
tions incubated with antibody blocked with antigen
served as controls. The sections were rinsed in PBS,
incubated with the biotinylated secondary antibody
against rabbit IgG (FEN-1) or mouse IgG (PCNA)
for 2 h, and subsequently incubated with the Vecta-
stain ABC reagent for 1 h. After being rinsed again
with PBS, the sections were incubated with peroxi-
dase substrate solution (diaminobenzidine), and then
examined with an Olympus microscope (Olympus,
Japan).
2.5. Oligonucleotide primers and RT-PCR
The oligonucleotide primers used in this study
were synthesized by Genosys (The Woodlands,
TX). Their sequences are: FEN-1 upper primer, 5P-
GCCAATCCAGGAATTCCACC-3P ; and FEN-1
lower primer, 5P-GATTCGCTCCTCAGAGAACT-
GCTT-3P. The RT-PCR reactions were carried out
using a mRNA Selective PCR Kit (TaKaRa, Shiga,
Japan) according to the procedures outlined by the
manufacturer. In brief, 5 Wg of total RNA extracted
from each sample was reverse-transcribed for 30 min
at 42‡C in 1UPCR bu¡er containing 5 mM MgCl2,
1 mM dNTP/analog mixture, RNase inhibitor, oli-
go(dT) primer and 0.1 U/Wl AMV reverse transcrip-
tase in a total volume of 50 Wl. Then 10 Wl of the RT
reactant was ampli¢ed in a total volume of 50 Wl.
The ampli¢cation was performed for 30 cycles under
the following reaction conditions: 5 mM MgCl2,
1 mM dNTP/analog mixture, 0.4 WM primers, 0.1
U/Wl Taq DNA polymerase; denaturation, 85‡C for
1 min; annealing, 55‡C for 1 min; extension, 72‡C
for 1 min. The 10 Wl of RT-PCR reaction was then
electrophoresed on a 1.5% agarose gel, and stained
with EtBr.
2.6. Northern blot analysis
Total cellular RNAs were isolated from the HL-60
cells treated with or without various reagents. Six
micrograms of RNA sample was electrophoresed
on a 1% agarose-formaldehyde gel and transferred
to a nylon membrane. The FEN-1 mRNA was ana-
lyzed by the DIG chemiluminescent detection meth-
od according to the procedure recommended by the
manufacturer (Boehringer Mannheim, Mannheim,
Germany). The probes, incorporated with DIG-11-
dUTP, were prepared by PCR ampli¢cation (606^
963-bp region of human FEN-1 cDNA and 294^
1131-bp region of human L-actin cDNA).
The FEN-1 genes expressed in eight di¡erent hu-
man tissues were also examined by Northern blot
analysis using a nylon membrane blotted poly(A)
RNA of 2 Wg, that was purchased from Clontech
(Palo Alto, CA).
3. Results
3.1. FEN-1 gene expression in mitotic cells
To examine whether FEN-1 could be induced dur-
ing cell proliferation, the FEN-1 mRNA levels in
mitotic lymphocytes and immature granulocytes
were compared with those in resting lymphocytes
and mature granulocytes using a RT-PCR method.
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As shown in Fig. 1, the mRNAs in peripheral blood
lymphocytes and granulocytes were detected at low
levels. However, the lymphocytes activated with
PHA and promyelocytic leukemia cells, which have
a much higher proliferating activity than resting lym-
phocytes and mature granulocytes, respectively, ex-
pressed this gene considerably more than their non-
growing counterpart cells. The levels of actin mRNA
were alike in all tested cells. These observations sug-
gest that the FEN-1 gene expression is up-regulated
in actively growing leukocytes.
3.2. Relationship between FEN-1 expression and in
vivo DNA synthesis
It has been well known that HL-60 promyelocytic
leukemia cells could be di¡erentiated into granulo-
cytes by DMSO or RA, and into monocytes/macro-
phages by TPA. In order to prepare non-growing
cells, terminal di¡erentiation of HL-60 cells was in-
duced by incubating them with 1.3% DMSO or 1 WM
RA for 7 days, or with 100 nM TPA for 5 days.
After incubation, cell di¡erentiation was evaluated
by Giemsa staining [17,19] and observation of the
completely blocked c-myc gene expression [20]
(data not shown). As shown in Fig. 2A, the fully
di¡erentiated HL-60 cells did not synthesize DNA
anymore, and also showed a remarkable decline in
FEN-1 gene expression (Fig. 2B and [17]). Fig. 3
shows cell growth, DNA synthesis and FEN-1
mRNA levels at di¡erent times after RA treatment.
The cell growth was retarded during cell di¡erentia-
tion. And the DNA synthesis in RA-treated HL-60
cells was decreased to 36%, 71% and 12% of that in
exponentially growing cells (cells cultured for 3 days
without RA) after 1, 3 and 5 days, respectively. The
change of FEN-1 mRNA levels correlated substan-
Fig. 1. Up-regulation of FEN-1 gene expression in mitotic cells.
Agarose gel electrophoresis patterns of RT-PCR products using
total RNA (0.2 Wg) extracted from the cells under di¡erent
growth conditions. Upper and lower panel show ampli¢ed 358
bp fragments of FEN-1 gene and 541 bp of L-actin, respec-
tively. Lymphocyte (Lym): peripheral (P), activated with PHA
(A); Granulocyte (Gra): peripheral (P), promyelocytic leukemia
cells (HL-60) (L).
Fig. 2. Down-regulation of FEN-1 expression in di¡erentiated HL-60 cells. HL-60 cells were treated with 1.3% DMSO or 1 WM RA
for 7 days, or with 100 nM TPA for 5 days. Control refers to HL-60 cells in exponential growth (cultured for 3 days without in-
ducer). (A) [3H]thymidine incorporation in the fully di¡erentiated HL-60 cells. Results are presented as the mean þ S.D. of triplicate
experiments. (B) Total RNA (6 Wg) was analyzed with a DIG-labeled PCR product of human FEN-1 cDNA (606^963 bp region) by
Northern blot (top). EtBr staining was used for RNA quantity (bottom).
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tially with that of DNA synthesis, suggesting a pos-
itive relationship between in vivo DNA synthesis and
FEN-1 gene expression.
3.3. Di¡erential expression of the FEN-1 in young rat
kidney
To further con¢rm the relationship between cell
proliferation and the FEN-1 enzyme, localization of
FEN-1 protein in rat tissue was observed using im-
munohistochemistry. First, a PCNA known as DNA
replication protein was immunostained using 3-Wm
consecutive sections of the kidney from a 5-day-old
rat, in order to identify the cell proliferating areas in
the renal cortex and corticomedullary junction. In
the renal cortex, most cells in the collecting ducts
were labeled with PCNA, whereas few cells were la-
beled in the proximal and distal tubules. Several glo-
meruli did not express PCNA (Fig. 4a). The staining
pattern in the corticomedullary junction was similar
to that in the cortex (Fig. 4c). Interestingly, FEN-1
could be detected in the area showing PCNA immu-
noreactivity (Fig. 4b,d), which implies that FEN-1
may participate in DNA replication.
3.4. Tissue-speci¢c human FEN-1 gene expression
Because there have been no previous studies show-
ing the gene expression of FEN-1 in speci¢c human
tissues, FEN-1 mRNA was analyzed in various hu-
man tissues. A nylon membrane (MTN), to which
2 Wg of poly(A)RNA from eight di¡erent human
tissues were transferred by Northern blotting, was
obtained from Clontech (Clontech, CA). Then the
FEN-1 gene transcript in each human tissue was in-
vestigated using a DIG-labeled FEN-1 probe (de-
scribed in Section 2). As the result of hybridization,
two bands, 2.3 and 1.8 kb, were detected (Fig. 5).
Fig. 3. Time course of DNA synthesis and FEN-1 gene expression during di¡erentiation. (A) The growth curve of HL-60 cells with
or without 1 WM RA for 5 days. Cell numbers were counted at the indicated times with a hemocytometer and were expressed as the
mean þ S.D. of triplicate experiments. (B) [3H]Thymidine incorporation at various times after RA treatment. Data were given as the
mean þ S.D. of triplicate experiments. (C) FEN-1 mRNA level at various times after RA treatment.
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The spleen and testis showed stronger signals than
the other tissues, and there were relatively weak sig-
nals in the thymus and mucosal lining of the colon.
In contrast, the prostate, ovary, small intestine and
peripheral blood leukocyte hardly expressed this
gene, whereas L-actin expressions were observed
very well in these tissues (Fig. 5). These results in-
dicate that the FEN-1 gene is more actively ex-
pressed in tissues containing proliferative immature
cells.
4. Discussion
Recent studies have indicated that FEN-1 acts on
DNA replication, i.e. : (1) mutant cells lacking in the
yeast RTH1 gene showed de¢cient cell growth [7]; (2)
yeast FEN-1 interacted with a replicative helicase
[21] as well as PCNA [22]; and (3) the calf FEN-1
homolog acted in the removal of the RNA primer
during Okazaki fragment maturation [11^13]. How-
ever, there is no study on the regulation of FEN-1
gene expression. In this study, we investigated FEN-
1 expression in cells under di¡erent cell-growth
stages. The result was that FEN-1 gene expression
was up-regulated in the actively growing cells and
was markedly down in the non-growing cells. In ad-
dition, there was a positive relationship between
FEN-1 expression and DNA synthesis. These ¢nd-
ings are similar to the results of several other studies
indicating that proteins acting in DNA replication,
Fig. 4. Light micrographs of immunostaining for PCNA (a,c) and FEN-1 (b,d) in 3-Wm consecutive sections of the kidney from
5-day-old rat. (a,b) In the renal cortex, immunostaining for PCNA and FEN-1 appeared simultaneously in the cells of the collecting
ducts (arrows). In the proximal and distal tubules, cells labeled for PCNA or FEN-1 were rare (arrowheads). Note that several glo-
meruli (G) were unlabeled for both antibodies. (c,d) In the corticomedullary junction, most cells of the collecting ducts were labeled
with PCNA or FEN-1 (arrows), whereas only a few cells were labeled in the proximal or distal tubules (arrowheads). U300.
Fig. 5. Tissue-speci¢c human FEN-1 expression. The membrane
blotted 2 Wg of poly(A)RNA from each tissue (MTN, Clon-
tech) was hybridized with the speci¢c probes to human FEN-1
(top) and L-actin (bottom). Lanes: 1, spleen; 2, thymus; 3,
prostate; 4, testis ; 5, ovary; 6, small intestine; 7, colon (mu-
cosal lining); and 8, peripheral blood leukocyte.
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such as DNA polymerase-K, PCNA and DNA ligase,
are inducible during cell proliferation, and down-
regulated during cell cycle exit [23^26]. Taken togeth-
er, it seems likely that FEN-1 expression can be regu-
lated for DNA replication.
When the FEN-1 mRNA was reverse-transcribed
and followed by cDNA ampli¢cation, only one
FEN-1-speci¢c band (358 bp) was observed (Fig.
1). To eliminate an ampli¢ed signal originating
from contaminated DNA, the mRNA Selective
PCR Kit (DaKaRa, Shiga, Japan) was used. How-
ever, the possibility of DNA-derived ampli¢cation
cannot be totally neglected. Actually, a little of the
FEN-1 signal showed up in peripheral blood lym-
phocytes and granulocytes by RT-PCR (Fig. 1),
whereas no signal was detected by the Northern
blot method (Fig. 5). However, because we were in-
terested in only relative mRNA levels among the
cells at the di¡erent growth stages, this was not con-
sidered. If the ampli¢ed mRNA levels were standard-
ized with the L-actin, the FEN-1 expression was
always higher in actively proliferating leukocyte cells.
According to our expectations, the induction of
terminal di¡erentiation of HL-60 promyelocytic leu-
kemia cells sharply decreased FEN-1 gene expres-
sion. This down-regulation was correlated with the
cessation of DNA synthesis. The size of mRNA ex-
pressed in human leukemia cells was about 2.3 kb
(Figs. 2 and 3). This is very close to the transcript
size (2.0 kb) of the human FEN-1 gene reported
previously [3].
Based on immunohistochemistry, the distribution
pattern of FEN-1 enzyme in young rat kidney was
similar to that of PCNA. Because it was analyzed
using very thin consecutive sections (3 Wm), this
data could be regarded as co-localization of FEN-1
and PCNA. Recent reports have demonstrated that
PCNA interacted with the C-terminus of FEN-1, and
that p21Cip1 disturbed this PCNA^FEN-1 binding
through competition for the binding site on PCNA
[15^16]. Therefore, there is a possibility that FEN-1
exists in a complex form with PCNA for DNA rep-
lication in the proliferating zones of renal tissues,
such as the collecting ducts. Supporting this possibil-
ity was the observation that the cells of collecting
ducts were not labeled in immunostaining for
PCNA if the cells were preincubated with antibody
against FEN-1 (data not shown), in contrast, the
cells which were not preincubated with anti-FEN-1
antibody were labeled well (Fig. 4a,c).
Two transcripts of the FEN-1 gene, 2.3 and 1.8 kb,
were detected in the human spleen and testis (Fig. 5),
whereas human leukemia cells have only one, about
2.3 kb (Figs. 2 and 3). We thought that the mRNA
of 1.8 kb in normal tissues was a degradated resul-
tant of intact mRNA. Hiraoka et al. reported on two
human FEN-1 genes localized in chromosome 1p22.2
and 11q12^q13 that one of these may be functional
(11q12^q13), and the other may be a pseudogene
(1p22.2) [4]. However, they also did not exclude the
possibility that the two genes are both functional. On
the basis of this possibility, the 2.3- and 1.8-kb tran-
scripts may be the products of two di¡erent genes.
The human FEN-1 gene (human homolog of
Schizosaccharomyces pombe rad2 gene) restored the
UV sensitivity of the yeast rad2 null mutant up to
wild-type levels [3]. In addition, a null mutation in
the yeast RTH1 gene showed an increased instability
of the simple repetitive DNA [27] which is associated
with human colorectal cancers, and human FEN-1
could e⁄ciently cleave UVDE-incised DNA sub-
strates with photolesions, such as pyrimidine dimers
[28]. Therefore, it has been hypothesized that FEN-1
participates in the DNA repair mechanism. Our
study did not include the FEN-1 expression during
DNA repair. That work is now ongoing.
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